A healthy gut may play a far more decisive role in women’s bone health than previously understood. New research conducted by the All India Institute of Medical Sciences (AIIMS) has uncovered a critical immune mechanism linking gut bacteria to bone loss in postmenopausal women. This discovery opens the door to safer, non-hormonal strategies—such as probiotics—for preventing osteoporosis.
Rethinking Osteoporosis Beyond Ageing and Hormones
For decades, clinicians largely viewed osteoporosis as an inevitable consequence of ageing and declining oestrogen levels. However, scientists now recognise that immune dysfunction also drives the disease. This evolving concept, known as Immunoporosis, has been championed by Dr Rupesh K Srivastava, Additional Professor in Translational Immunology, Osteoimmunology, and head of the Immunoporosis Lab—an ICMR-collaborative Centre of Excellence in Bone Health.
According to Dr Srivastava, postmenopausal oestrogen deficiency triggers chronic inflammation, which disrupts the immune system’s ability to protect bone integrity.
How Immune Imbalance Accelerates Bone Loss
At the centre of this immune disruption are regulatory T cells, or Tregs—specialised immune cells that normally suppress excessive inflammation and help preserve bone health. The study revealed that menopause alters the balance between different Treg populations, particularly those generated in peripheral tissues such as the gut.
As this balance deteriorates, protective Tregs increasingly convert into inflammatory Th17 cells. These Th17 cells actively stimulate bone resorption, accelerating bone loss and significantly increasing the risk of osteoporosis after menopause.
The Gut: Ground Zero for Postmenopausal Bone Damage
Crucially, the researchers identified the gut as the primary site where this harmful immune shift originates. The intestinal environment, influenced by gut bacteria, appears to determine whether immune cells protect bones or contribute to their destruction.
This insight marked a turning point in the study and prompted researchers to explore whether modifying gut bacteria could restore immune balance.
Probiotics Show Promise in Restoring Immune Balance
To test this theory, the team studied the effects of Lactobacillus acidophilus, a widely used probiotic. Supplementation with this beneficial bacterium successfully restored immune equilibrium in the gut. Specifically, it reduced the excessive rise in inflammatory Th17 cells while stabilising protective Treg populations.
This effect was mediated by butyrate, a short-chain fatty acid produced in the gut that is well known for its anti-inflammatory properties.
Direct Link Between Gut Immunity and Bone Preservation
Even more compelling, immune cells “primed” by butyrate showed a markedly reduced ability to activate osteoclasts—the cells responsible for bone erosion. This finding directly connects gut-derived immune signals to bone preservation and provides strong mechanistic evidence linking intestinal health to skeletal strength.
Researchers believe this is the first study to clearly define a gut-based immune pathway driving postmenopausal osteoporosis.
A Shift Toward Safer, Non-Hormonal Therapies
As reported by TOI, the findings add to growing evidence that osteoporosis is not merely a bone disorder, but a systemic immune condition strongly influenced by gut health. Given long-term safety concerns associated with many existing osteoporosis medications, this discovery could significantly reshape future treatment approaches.
Experts suggest that probiotics and other immune-modulating therapies may eventually complement—or in some cases reduce reliance on—conventional drugs, offering women safer options to protect bone health after menopause.
The Takeaway: Protect the Gut to Protect the Bones
As scientific understanding evolves, one message becomes increasingly clear: caring for gut health may be central to safeguarding skeletal health. By targeting immune balance through the gut, future therapies could redefine how osteoporosis is prevented and managed in postmenopausal women.